sorafenib has been researched along with fucose in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (fucose) | Trials (fucose) | Recent Studies (post-2010) (fucose) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 5,584 | 26 | 1,198 |
| Protein | Taxonomy | sorafenib (IC50) | fucose (IC50) |
|---|---|---|---|
| Fucose-binding lectin PA-IIL | Pseudomonas aeruginosa PAO1 | 2.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arihara, Y; Hayasaka, N; Kamihara, Y; Kato, J; Kikuchi, S; Kobune, M; Miyanishi, K; Murase, K; Nakamura, H; Okagawa, Y; Osuga, T; Takada, K; Usami, M | 1 |
1 other study(ies) available for sorafenib and fucose
| Article | Year |
|---|---|
Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Drug Synergism; Fucose; Fucosyltransferases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Liposomes; Liver Neoplasms; Mice; Niacinamide; Phenylurea Compounds; Sorafenib; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |